Clinical Trial Update: A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data

View source ↗

Summary

A real-world data analysis comparing a sumatriptan and naproxen sodium combination product with single-entity oral triptans for migraine disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Naproxen sodium (naproxen sodium)
• Sumatriptan (Sumatriptan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Status: COMPLETED